DE69528068D1 - Conagenine zur prävention und behandlung von diarrhöe - Google Patents

Conagenine zur prävention und behandlung von diarrhöe

Info

Publication number
DE69528068D1
DE69528068D1 DE69528068T DE69528068T DE69528068D1 DE 69528068 D1 DE69528068 D1 DE 69528068D1 DE 69528068 T DE69528068 T DE 69528068T DE 69528068 T DE69528068 T DE 69528068T DE 69528068 D1 DE69528068 D1 DE 69528068D1
Authority
DE
Germany
Prior art keywords
conagenine
diarrhoe
prevention
treatment
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69528068T
Other languages
English (en)
Other versions
DE69528068T2 (de
Inventor
Masaaki Ishizuka
Kenji Maeda
Tomio Takeuchi
Toshiyuki Toko
Tadayoshi Shiraishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Taiho Pharmaceutical Co Ltd
Original Assignee
Microbial Chemistry Research Foundation
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation, Taiho Pharmaceutical Co Ltd filed Critical Microbial Chemistry Research Foundation
Publication of DE69528068D1 publication Critical patent/DE69528068D1/de
Application granted granted Critical
Publication of DE69528068T2 publication Critical patent/DE69528068T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE69528068T 1994-10-14 1995-10-13 Conagenine zur prävention und behandlung von diarrhöe Expired - Fee Related DE69528068T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24946694 1994-10-14
JP20820195A JP4078397B2 (ja) 1994-10-14 1995-08-15 下痢の予防及び治療剤
PCT/JP1995/002107 WO1996011681A1 (fr) 1994-10-14 1995-10-13 Antidiarrheique therapeutique et preventif

Publications (2)

Publication Number Publication Date
DE69528068D1 true DE69528068D1 (de) 2002-10-10
DE69528068T2 DE69528068T2 (de) 2003-10-02

Family

ID=26516699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528068T Expired - Fee Related DE69528068T2 (de) 1994-10-14 1995-10-13 Conagenine zur prävention und behandlung von diarrhöe

Country Status (9)

Country Link
US (1) US5952380A (de)
EP (1) EP0783884B1 (de)
JP (1) JP4078397B2 (de)
KR (1) KR100369890B1 (de)
AT (1) ATE223212T1 (de)
AU (1) AU691674B2 (de)
CA (1) CA2202389A1 (de)
DE (1) DE69528068T2 (de)
WO (1) WO1996011681A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4078397B2 (ja) * 1994-10-14 2008-04-23 財団法人微生物化学研究会 下痢の予防及び治療剤
US6160017A (en) * 1997-04-09 2000-12-12 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Preventives and remedies for ulcerous colitis and/or crohn's disease
JPWO2007011066A1 (ja) * 2005-07-22 2009-02-05 株式会社カネカ 繊維芽細胞賦活剤、コラーゲン産生促進剤、コラーゲン収縮促進剤、ヒアルロン酸産生促進剤、ａｔｐ産生促進剤、メラニン生成抑制剤、皮膚外用剤
CN110714050A (zh) * 2018-07-13 2020-01-21 永州职业技术学院 一种基于多种微生物的急性毒性试验方法及其试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2837870B2 (ja) * 1989-05-23 1998-12-16 財団法人微生物化学研究会 新規な制癌抗生物質コナゲニン及びその製造法
JPH04112865A (ja) * 1990-09-03 1992-04-14 Dainippon Pharmaceut Co Ltd 置換アミド誘導体
JPH0798752B2 (ja) * 1991-08-09 1995-10-25 株式会社ツムラ β−グルクロニダーゼ阻害剤
JPH0665072A (ja) * 1992-08-17 1994-03-08 Microbial Chem Res Found 化学療法剤及び又は放射線による副作用の軽減剤
JP4078397B2 (ja) * 1994-10-14 2008-04-23 財団法人微生物化学研究会 下痢の予防及び治療剤

Also Published As

Publication number Publication date
WO1996011681A1 (fr) 1996-04-25
AU3673795A (en) 1996-05-06
EP0783884A4 (de) 1999-06-23
US5952380A (en) 1999-09-14
ATE223212T1 (de) 2002-09-15
KR970705987A (ko) 1997-11-03
JPH08165236A (ja) 1996-06-25
KR100369890B1 (ko) 2003-05-12
JP4078397B2 (ja) 2008-04-23
AU691674B2 (en) 1998-05-21
CA2202389A1 (en) 1996-04-25
EP0783884A1 (de) 1997-07-16
EP0783884B1 (de) 2002-09-04
DE69528068T2 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
KR920019342A (ko) 골질환 치료제
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
ATE359074T1 (de) Raloxifene in der behandlung von postmeopausal osteoporose
ATE142489T1 (de) Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
DE69500673T2 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
DE69835461D1 (de) Anti-arrhythmische Zusammensetzungen und Behandlungsverfahren
ATE139440T1 (de) Behandlung von entzündlichen darmerkrankungen
DE69528068D1 (de) Conagenine zur prävention und behandlung von diarrhöe
GR3032224T3 (en) Therapeutic agent for threatened abortion.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
SE9001308L (sv) Foerfarande foer att behandla och foerebygga foertvining av bensubstans
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
ATE99930T1 (de) Mischung von vitamin a in physiologischer dosis und verschiedenen wirkstoffen mit therapeutischer wirksamkeit.
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
KR930702016A (ko) 골다공증 치료제
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
WO2000002578A8 (fr) Remedes contre les maladies liees a l'apoptose
CA2197139A1 (en) A drug for the treatment of cancer
KR930019216A (ko) 종양 치료제
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee